Skip to main content

Table 1 Comparison of odds and estimated annual percentage change (EAPC)

From: Quantifying temporal trends of age-standardized rates with odds

 

Male

Female

Sitea

Odds

Median (1Q; 3Q)

EAPC

Median (1Q; 3Q)

Concordance (%)

Odds

Median (1Q; 3Q)

EAPC

Median (1Q; 3Q)

Concordance (%)

All sites but non-melanoma skin

1.18 (1.1; 1.29)

0.83 (0.43; 1.13)

85

1.21 (1.13; 1.39)

0.71 (0.44; 1.17)

85

Prostate

1.43 (1.22; 1.67)

4.38 (3.14; 5.73)

95

   

Breast

   

1.24 (1.15; 1.46)

1.52 (0.96; 2.11)

88

Stomach

0.79 (0.66; 0.87)

−2.42 (− 3.08; − 1.79)

91

0.83 (0.71; 0.90)

− 2.40 (− 3.20; − 1.64)

82

Lung

0.92 (0.77; 1.02)

− 1.22 (− 1.80; 0.11)

76

1.17 (1.09; 1.33)

1.98 (0.98; 3.56)

78

Cervix uteri

   

0.85 (0.79; 0.94)

−2.46 (− 3.44; − 1.08)

76

Thyroid

1.10 (1.05; 1.18)

2.75 (1.52; 4.27)

69

1.18 (1.11; 1.34)

3.46 (2.11; 5.54)

84

Kidney etc.

1.16 (1.08; 1.25)

1.93 (1.46; 2.70)

81

1.12 (1.07; 1.18)

2.05 (1.22; 2.45)

70

Non-Hodgkin Lymphoma

1.14 (1.08; 1.21)

1.91 (1.31; 2.44)

75

1.17 (1.10; 1.24)

2.06 (1.43; 2.83)

77

Melanoma of skin

1.22 (1.07; 1.45)

3.46 (2.01; 4.77)

75

1.17 (1.06; 1.32)

2.89 (1.25; 4.37)

70

Liver

1.14 (1.07; 1.27)

2.70 (0.97; 3.67)

78

1.07 (1.01; 1.15)

1.75 (−0.04; 3.01)

54

Colon

1.09 (1.01; 1.25)

0.85 (− 0.01; 2.36)

69

1.04 (0.97; 1.18)

0.29 (−0.38; 1.94)

62

Corpus uteri

   

1.10 (1.01; 1.19)

0.95 (−0.02; 1.84)

62

Oral cavity & pharynx

0.96 (0.88; 1.02)

−0.67 (−1.6; 0.14)

62

1.04 (0.96; 1.09)

0.64 (−0.92; 1.56)

53

Ovary/other uterine adnexa

   

0.99 (0.94; 1.05)

−0.29 (− 0.74; 0.54)

50

Esophagus

1.00 (0.92; 1.09)

−0.15 (−1.84; 1.33)

59

0.99 (0.92; 1.04)

−0.34 (−2.13; 0.86)

40

Rectum and anus

1.06 (1.00; 1.15)

0.69 (−0.07; 1.51)

55

1.03 (1.00; 1.09)

0.35 (−0.20; 0.9)

42

Larynx

0.92 (0.84; 0.97)

−1.85 (−2.50; −0.71)

61

1.00 (0.95; 1.03)

−0.47 (−2.21; 1.06)

29

Bladder

1.04 (0.99; 1.11)

0.39 (−0.16; 1.44)

47

1.03 (0.99; 1.09)

0.44 (−0.33; 1.50)

40

Pancreas

1.02 (0.97; 1.06)

0.10 (−0.50; 1.02)

44

1.05 (1.01; 1.10)

0.51 (0.04; 1.81)

36

Leukemia

1.03 (1; 1.07)

0.29 (−0.04; 0.88)

31

1.04 (1.00; 1.08)

0.48 (0.03; 0.98)

37

Brain and central nervous system

1.03 (1; 1.07)

0.49 (−0.13; 0.97)

33

1.03 (1.00; 1.06)

0.54 (−0.07; 1.36)

32

  1. aCancer sites were ordered by the percentage concordance in the significance between the odds from rank-ordered logit and EAPC from the weighted linear regression of log-transformed rates, which indicates the strength and persistence of evidence of a temporal trend across the 118 populations in CI5plus. Abbreviations: 1Q First quartile, 3Q Third quartile